CX3CL1 and B-cell chronic lymphocytic leukemia: Plasma concentrations of CX3CL1 in patients with non-active (n = 59) and active CLL (n = 29) were significantly higher than in healthy donors (n = 32) (p < 0.05 and p < 0.0001, respectively).